Utah Medical Products (UTMD)
Makes specialty medical devices for labor, neonatal, gynecology, urology, and pressure-monitoring settings.
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESS Newswire / August 4, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on October 5, 2026 to stockholders of record at the close of business on September 17, 2026. This is a 1.6% increase over the dividend declared in the same quarter of the prior year.
Utah Medical's Q2 Earnings Down Y/Y Due to Customer Losses
UTMD's Q2 earnings per share decline 10.1% year over year, while quarterly revenues face pressure from lost customers and slower new business growth.
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2026
SALT LAKE CITY, UT / ACCESS Newswire / July 23, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) reports second calendar quarter (2Q) and first half (1H) 2026 financial results with a continued decline in overall revenues in comparison to the same time periods in 2025. Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros.
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESS Newswire / May 5, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on July 3, 2026 to stockholders of record at the close of business on June 17, 2026. This is a 1.6% increase over the dividend declared in the same quarter of the prior year.
Utah Medical's Q1 Earnings Fall Y/Y Due to Elevated Litigation Costs
UTMD reports a year-over-year decline in Q1 earnings per share and sales, pressured by lost distributor business and higher costs, despite improved margins and a strong balance sheet.
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2026
SALT LAKE CITY, UT / ACCESS Newswire / April 23, 2026 / In the first calendar quarter (1Q) of 2026, Utah Medical Products, Inc. (Nasdaq:UTMD) attained financial results which were consistent with its previously announced projections for calendar year 2026. But because of the relatively short span of time, results for any given three-month period in comparison with a previous three-month period may not be indicative of comparative results for the year as a whole.
Head-To-Head Comparison: Utah Medical Products (NASDAQ:UTMD) and INLIF (NASDAQ:INLF)
Utah Medical Products (NASDAQ: UTMD - Get Free Report) and INLIF (NASDAQ: INLF - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, dividends, risk and analyst recommendations. Analyst Recommendations This is a breakdown of
Utah Medical Gains 32% in a Year: Should You Buy the Stock?
UTMD's niche leadership, global footprint, and strong cash generation position it to benefit from rising demand for high-quality maternal and neonatal healthcare solutions.
Utah Medical Products (NASDAQ:UTMD) Stock Passes Above 200 Day Moving Average – Here’s What Happened
Utah Medical Products, Inc. (NASDAQ: UTMD - Get Free Report) passed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $60.53 and traded as high as $65.56. Utah Medical Products shares last traded at $63.80, with a volume of 12,991 shares changing hands.
Utah Medical's Q4 Earnings Hurt by OEM Decline, Fall Y/Y
UTMD's Q4 earnings fall year over year due to weak OEM sales and lower international Filshie sales, but strong U.S. Filshie growth and steady margins help offset broader revenue pressure.
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESS Newswire / February 4, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on April 3, 2026 to stockholders of record at the close of business on March 17, 2026. This is a 1.6% increase over the dividend declared in the same quarter of the prior year.
UTMD Reports Year 2025 and Fourth Quarter Financial Performance
SALT LAKE CITY, UT / ACCESS Newswire / January 29, 2026 / With some unexpected circumstances in 2025, Utah Medical Products, Inc (UTMD) did not achieve its beginning of year financial projections. Nevertheless the Company retained excellent profit margins, and increased its year-ending cash balances to $85.8 million despite paying $4.0 million in dividends to stockholders and repurchasing 4.5% (since the end of 2024) of its shares in the open market for $8.4 million.
Utah Medical Products (NASDAQ:UTMD) Shares Cross Above Fifty Day Moving Average – Time to Sell?
Shares of Utah Medical Products, Inc. (NASDAQ: UTMD - Get Free Report) crossed above its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $56.49 and traded as high as $58.76. Utah Medical Products shares last traded at $57.60, with a volume of 19,913 shares changing hands. Analyst Ratings
Comparing Utah Medical Products (NASDAQ:UTMD) and Terumo (OTCMKTS:TRUMY)
Terumo (OTCMKTS:TRUMY - Get Free Report) and Utah Medical Products (NASDAQ: UTMD - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, profitability, institutional ownership, risk, dividends and earnings. Insider and Institutional Ownership 69.6% of Utah Medical
Utah Medical Products (NASDAQ:UTMD) Stock Crosses Below 200 Day Moving Average – Here’s What Happened
Utah Medical Products, Inc. (NASDAQ: UTMD - Get Free Report)'s share price passed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $58.26 and traded as low as $57.12. Utah Medical Products shares last traded at $57.39, with a volume of 10,823 shares trading hands. Analysts Set
Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend
SALT LAKE CITY, UT / ACCESS Newswire / November 4, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors has appointed Kevin C. Timken, Esq to its Board of Directors.
UTMD's Q3 Earnings Dip Y/Y on Trade Disruptions, Margins Squeeze
Utah Medical's Q3 earnings fell 20% year over year as order cancellations and tariffs pressured margins. Growth in U.S. Filshie devices and direct sales helped partially offset declines.
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2025
SALT LAKE CITY, UT / ACCESS Newswire / October 23, 2025 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2025 financial results that were unusually hampered by global trade uncertainty. Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros.
UTMD's Q2 Earnings Slip Y/Y Due to Falling OEM Sales, Stock Down 3%
Utah Medical's Q2 earnings decrease year over year on lower OEM sales and weak international demand, though cost controls helped cushion margins.
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESS Newswire / July 29, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty and one-half cents ($.305) per share of common stock payable on October 2, 2025 to stockholders of record at the close of business on September 17, 2025. This is a 1.7% increase over the dividend declared in the same quarter of the prior year.